Lipid-induced phenotypes.
Schultz
Carsten
C
D000813:Anilides / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D006801:Humans; D008246:Lysophospholipids / Q000494:pharmacology / Q000502:physiology*; D008954:Models, Biological; D063065:Organophosphonates / Q000494:pharmacology; D010641:Phenotype; D049349:Receptors, Lysosphingolipid / Q000819:agonists / Q000037:antagonists & inhibitors / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000502:physiology
C513113:3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid; D000813:Anilides; D008246:Lysophospholipids; D063065:Organophosphonates; D049349:Receptors, Lysosphingolipid; C060506:sphingosine 1-phosphate; D013110:Sphingosine